- Record: found
- Abstract: found
- Article: not found
A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma.
Eileen M OʼReilly
1 ,
Anna Perelshteyn ,
William R Jarnagin ,
Mark Schattner ,
Hans Gerdes ,
Marinela Capanu ,
Laura H Tang ,
Joseph LaValle ,
Corinne Winston ,
Ronald P DeMatteo ,
Michael DʼAngelica ,
Robert C Kurtz ,
Ghassan K Abou-Alfa ,
David S Klimstra ,
Maeve A Lowery ,
Murray F Brennan ,
Daniel G Coit ,
Diane L Reidy ,
T Peter Kingham ,
Peter J Allen
Jul 2014
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The role for neoadjuvant systemic therapy in resectable pancreas adenocarcinoma remains undefined.